1	1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Introduction	_	_	NN	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	many	_	_	JJ	_	_	_	_	_
3	clinical	_	_	JJ	_	_	_	_	_
4	specialties	_	_	NNS	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	there	_	_	EX	_	_	_	_	_
7	exists	_	_	VBZ	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	high	_	_	JJ	_	_	_	_	_
10	variety	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	image	_	_	NN	_	_	_	_	_
13	modalities	_	_	NNS	_	_	_	_	_
14	that	_	_	WDT	_	_	_	_	_
15	clinicians	_	_	NNS	_	_	_	_	_
16	typically	_	_	RB	_	_	_	_	_
17	use	_	_	VBP	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	analyze	_	_	VB	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	patient	_	_	NN	_	_	_	_	_
22	’s	_	_	POS	_	_	_	_	_
23	condition	_	_	NN	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	aid	_	_	NN	_	_	_	_	_
26	in	_	_	IN	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	diagnostic	_	_	JJ	_	_	_	_	_
29	process	_	_	NN	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	Given	_	_	VBN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	importance	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	technology	_	_	NN	_	_	_	_	_
6	at	_	_	IN	_	_	_	_	_
7	present	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	namely	_	_	RB	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	its	_	_	PRP$	_	_	_	_	_
12	inclusion	_	_	NN	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	different	_	_	JJ	_	_	_	_	_
15	areas	_	_	NNS	_	_	_	_	_
16	to	_	_	TO	_	_	_	_	_
17	improve	_	_	VB	_	_	_	_	_
18	an	_	_	DT	_	_	_	_	_
19	expert	_	_	NN	_	_	_	_	_
20	’s	_	_	POS	_	_	_	_	_
21	work	_	_	NN	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	many	_	_	JJ	_	_	_	_	_
24	computational	_	_	JJ	_	_	_	_	_
25	systems	_	_	NNS	_	_	_	_	_
26	have	_	_	VBP	_	_	_	_	_
27	been	_	_	VBN	_	_	_	_	_
28	implemented	_	_	VBN	_	_	_	_	_
29	to	_	_	TO	_	_	_	_	_
30	facilitate	_	_	VB	_	_	_	_	_
31	this	_	_	DT	_	_	_	_	_
32	clinical	_	_	JJ	_	_	_	_	_
33	processes	_	_	NNS	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	automatization	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	different	_	_	JJ	_	_	_	_	_
5	clinical	_	_	JJ	_	_	_	_	_
6	manual	_	_	NN	_	_	_	_	_
7	tasks	_	_	NNS	_	_	_	_	_
8	provide	_	_	VBP	_	_	_	_	_
9	solutions	_	_	NNS	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	improvements	_	_	NNS	_	_	_	_	_
12	that	_	_	WDT	_	_	_	_	_
13	are	_	_	VBP	_	_	_	_	_
14	characterized	_	_	VBN	_	_	_	_	_
15	by	_	_	IN	_	_	_	_	_
16	desirable	_	_	JJ	_	_	_	_	_
17	properties	_	_	NNS	_	_	_	_	_
18	that	_	_	WDT	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	expert	_	_	NN	_	_	_	_	_
21	cannot	_	_	MD	_	_	_	_	_
22	offer	_	_	VB	_	_	_	_	_
23	such	_	_	JJ	_	_	_	_	_
24	as	_	_	IN	_	_	_	_	_
25	determinism	_	_	NN	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	repeatability	_	_	NN	_	_	_	_	_
28	or	_	_	CC	_	_	_	_	_
29	objectivity	_	_	NN	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	Regarding	_	_	VBG	_	_	_	_	_
2	image	_	_	NN	_	_	_	_	_
3	analysis	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	over	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	years	_	_	NNS	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	many	_	_	JJ	_	_	_	_	_
10	computational	_	_	JJ	_	_	_	_	_
11	proposals	_	_	NNS	_	_	_	_	_
12	have	_	_	VBP	_	_	_	_	_
13	been	_	_	VBN	_	_	_	_	_
14	presented	_	_	VBN	_	_	_	_	_
15	based	_	_	VBN	_	_	_	_	_
16	on	_	_	IN	_	_	_	_	_
17	computer	_	_	NN	_	_	_	_	_
18	vision	_	_	NN	_	_	_	_	_
19	techniques	_	_	NNS	_	_	_	_	_
20	that	_	_	WDT	_	_	_	_	_
21	are	_	_	VBP	_	_	_	_	_
22	exploited	_	_	VBN	_	_	_	_	_
23	to	_	_	TO	_	_	_	_	_
24	analyze	_	_	VB	_	_	_	_	_
25	relevant	_	_	JJ	_	_	_	_	_
26	areas	_	_	NNS	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	images	_	_	NNS	_	_	_	_	_
30	of	_	_	IN	_	_	_	_	_
31	interest	_	_	NN	_	_	_	_	_
32	,	_	_	,	_	_	_	_	_
33	measure	_	_	VB	_	_	_	_	_
34	relevant	_	_	JJ	_	_	_	_	_
35	parameters	_	_	NNS	_	_	_	_	_
36	and	_	_	CC	_	_	_	_	_
37	monitor	_	_	VB	_	_	_	_	_
38	their	_	_	PRP$	_	_	_	_	_
39	evolution	_	_	NN	_	_	_	_	_
40	and	_	_	CC	_	_	_	_	_
41	potential	_	_	JJ	_	_	_	_	_
42	variations	_	_	NNS	_	_	_	_	_
43	,	_	_	,	_	_	_	_	_
44	which	_	_	WDT	_	_	_	_	_
45	is	_	_	VBZ	_	_	_	_	_
46	the	_	_	DT	_	_	_	_	_
47	typical	_	_	JJ	_	_	_	_	_
48	procedure	_	_	NN	_	_	_	_	_
49	that	_	_	WDT	_	_	_	_	_
50	is	_	_	VBZ	_	_	_	_	_
51	used	_	_	VBN	_	_	_	_	_
52	in	_	_	IN	_	_	_	_	_
53	many	_	_	JJ	_	_	_	_	_
54	Computer	_	_	NNP	_	_	_	_	_
55	Aided	_	_	NNP	_	_	_	_	_
56	Diagnostic	_	_	NNP	_	_	_	_	_
57	(	_	_	-LRB-	_	_	_	_	_
58	CAD	_	_	NNP	_	_	_	_	_
59	)	_	_	-RRB-	_	_	_	_	_
60	systems	_	_	NNS	_	_	_	_	_
61	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	ophthalmology	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	different	_	_	JJ	_	_	_	_	_
5	image	_	_	NN	_	_	_	_	_
6	modalities	_	_	NNS	_	_	_	_	_
7	have	_	_	VBP	_	_	_	_	_
8	increased	_	_	VBN	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	popularity	_	_	NN	_	_	_	_	_
11	over	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	last	_	_	JJ	_	_	_	_	_
14	years	_	_	NNS	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	color	_	_	NN	_	_	_	_	_
3	fundus	_	_	NN	_	_	_	_	_
4	retinography	_	_	NN	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	most	_	_	RBS	_	_	_	_	_
8	traditional	_	_	JJ	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	widely	_	_	RB	_	_	_	_	_
11	extended	_	_	VBN	_	_	_	_	_
12	ophthalmic	_	_	JJ	_	_	_	_	_
13	image	_	_	NN	_	_	_	_	_
14	modality	_	_	NN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	that	_	_	WDT	_	_	_	_	_
17	allows	_	_	VBZ	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	direct	_	_	JJ	_	_	_	_	_
20	visualization	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	eye	_	_	NN	_	_	_	_	_
24	fundus	_	_	NN	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	their	_	_	PRP$	_	_	_	_	_
27	possible	_	_	JJ	_	_	_	_	_
28	pathological	_	_	JJ	_	_	_	_	_
29	visible	_	_	JJ	_	_	_	_	_
30	structures	_	_	NNS	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	Being	_	_	VBG	_	_	_	_	_
2	an	_	_	DT	_	_	_	_	_
3	invasive	_	_	JJ	_	_	_	_	_
4	capture	_	_	NN	_	_	_	_	_
5	technique	_	_	NN	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	Fluorescein	_	_	NNP	_	_	_	_	_
9	Angiography	_	_	NNP	_	_	_	_	_
10	(	_	_	-LRB-	_	_	_	_	_
11	FA	_	_	NNP	_	_	_	_	_
12	)	_	_	-RRB-	_	_	_	_	_
13	provides	_	_	VBZ	_	_	_	_	_
14	an	_	_	DT	_	_	_	_	_
15	enhanced	_	_	VBN	_	_	_	_	_
16	visualization	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	retinal	_	_	JJ	_	_	_	_	_
20	vascular	_	_	JJ	_	_	_	_	_
21	structure	_	_	NN	_	_	_	_	_
22	by	_	_	IN	_	_	_	_	_
23	injecting	_	_	VBG	_	_	_	_	_
24	a	_	_	DT	_	_	_	_	_
25	dye	_	_	NN	_	_	_	_	_
26	contrast	_	_	NN	_	_	_	_	_
27	into	_	_	IN	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	patient	_	_	NN	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	With	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	Optical	_	_	NNP	_	_	_	_	_
4	Coherence	_	_	NNP	_	_	_	_	_
5	Tomography	_	_	NNP	_	_	_	_	_
6	(	_	_	-LRB-	_	_	_	_	_
7	OCT	_	_	NNP	_	_	_	_	_
8	)	_	_	-RRB-	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	we	_	_	PRP	_	_	_	_	_
11	can	_	_	MD	_	_	_	_	_
12	visualize	_	_	VB	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	analyze	_	_	VB	_	_	_	_	_
15	volumetric	_	_	JJ	_	_	_	_	_
16	scans	_	_	NNS	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	inner	_	_	JJ	_	_	_	_	_
20	retinal	_	_	JJ	_	_	_	_	_
21	layers	_	_	NNS	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	non-invasively	_	_	RB	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	in	_	_	IN	_	_	_	_	_
26	real	_	_	JJ	_	_	_	_	_
27	time	_	_	NN	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	Based	_	_	VBN	_	_	_	_	_
2	on	_	_	IN	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	OCT	_	_	NNP	_	_	_	_	_
5	and	_	_	CC	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	FA	_	_	NNP	_	_	_	_	_
8	characteristics	_	_	NNS	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	a	_	_	DT	_	_	_	_	_
11	new	_	_	JJ	_	_	_	_	_
12	image	_	_	NN	_	_	_	_	_
13	modality	_	_	NN	_	_	_	_	_
14	appeared	_	_	VBD	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	combining	_	_	VBG	_	_	_	_	_
17	both	_	_	CC	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	OCT	_	_	NNP	_	_	_	_	_
20	benefits	_	_	NNS	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	FA	_	_	NNP	_	_	_	_	_
24	visualization	_	_	NN	_	_	_	_	_
25	:	_	_	:	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	Optical	_	_	NNP	_	_	_	_	_
28	Coherence	_	_	NNP	_	_	_	_	_
29	Tomography	_	_	NNP	_	_	_	_	_
30	by	_	_	IN	_	_	_	_	_
31	Angiography	_	_	NNP	_	_	_	_	_
32	(	_	_	-LRB-	_	_	_	_	_
33	OCTA	_	_	NNP	_	_	_	_	_
34	)	_	_	-RRB-	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_


1	OCTA	_	_	NNP	_	_	_	_	_
2	imaging	_	_	NN	_	_	_	_	_
3	constitutes	_	_	VBZ	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	new	_	_	JJ	_	_	_	_	_
6	ophthalmic	_	_	JJ	_	_	_	_	_
7	image	_	_	NN	_	_	_	_	_
8	modality	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	it	_	_	PRP	_	_	_	_	_
12	is	_	_	VBZ	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	first	_	_	JJ	_	_	_	_	_
15	that	_	_	WDT	_	_	_	_	_
16	allows	_	_	VBZ	_	_	_	_	_
17	an	_	_	DT	_	_	_	_	_
18	exhaustive	_	_	JJ	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	non-invasive	_	_	JJ	_	_	_	_	_
21	vascular	_	_	JJ	_	_	_	_	_
22	analysis	_	_	NN	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	retina	_	_	NN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	OCTA	_	_	NNP	_	_	_	_	_
2	accurately	_	_	RB	_	_	_	_	_
3	represents	_	_	VBZ	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	vascularity	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	foveal	_	_	JJ	_	_	_	_	_
9	region	_	_	NN	_	_	_	_	_
10	within	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	retinal	_	_	JJ	_	_	_	_	_
13	layers	_	_	NNS	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	representation	_	_	NN	_	_	_	_	_
3	is	_	_	VBZ	_	_	_	_	_
4	extracted	_	_	VBN	_	_	_	_	_
5	based	_	_	VBN	_	_	_	_	_
6	on	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	blood	_	_	NN	_	_	_	_	_
9	movement	_	_	NN	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	eye	_	_	NN	_	_	_	_	_
13	microvasculature	_	_	NN	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	Given	_	_	VBN	_	_	_	_	_
2	that	_	_	IN	_	_	_	_	_
3	numerous	_	_	JJ	_	_	_	_	_
4	systematic	_	_	JJ	_	_	_	_	_
5	and	_	_	CC	_	_	_	_	_
6	eye	_	_	NN	_	_	_	_	_
7	diseases	_	_	NNS	_	_	_	_	_
8	are	_	_	VBP	_	_	_	_	_
9	related	_	_	VBN	_	_	_	_	_
10	with	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	microvascular	_	_	JJ	_	_	_	_	_
13	circulation	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	OCTA	_	_	NNP	_	_	_	_	_
16	constitutes	_	_	VBZ	_	_	_	_	_
17	a	_	_	DT	_	_	_	_	_
18	relevant	_	_	JJ	_	_	_	_	_
19	new	_	_	JJ	_	_	_	_	_
20	ophthalmic	_	_	JJ	_	_	_	_	_
21	image	_	_	NN	_	_	_	_	_
22	modality	_	_	NN	_	_	_	_	_
23	that	_	_	WDT	_	_	_	_	_
24	better	_	_	RBR	_	_	_	_	_
25	aids	_	_	VBZ	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	diagnosis	_	_	NN	_	_	_	_	_
28	and	_	_	CC	_	_	_	_	_
29	monitoring	_	_	NN	_	_	_	_	_
30	processes	_	_	NNS	_	_	_	_	_
31	of	_	_	IN	_	_	_	_	_
32	these	_	_	DT	_	_	_	_	_
33	pathologies	_	_	NNS	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	As	_	_	IN	_	_	_	_	_
2	reference	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	diseases	_	_	NNS	_	_	_	_	_
5	such	_	_	JJ	_	_	_	_	_
6	as	_	_	IN	_	_	_	_	_
7	diabetes	_	_	NN	_	_	_	_	_
8	can	_	_	MD	_	_	_	_	_
9	generate	_	_	VB	_	_	_	_	_
10	a	_	_	DT	_	_	_	_	_
11	Diabetic	_	_	NNP	_	_	_	_	_
12	Retinopathy	_	_	NNP	_	_	_	_	_
13	(	_	_	-LRB-	_	_	_	_	_
14	DR	_	_	NNP	_	_	_	_	_
15	)	_	_	-RRB-	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	which	_	_	WDT	_	_	_	_	_
18	provokes	_	_	VBZ	_	_	_	_	_
19	microvascular	_	_	JJ	_	_	_	_	_
20	problems	_	_	NNS	_	_	_	_	_
21	in	_	_	IN	_	_	_	_	_
22	advanced	_	_	JJ	_	_	_	_	_
23	stages	_	_	NNS	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	disease	_	_	NN	_	_	_	_	_
27	,	_	_	,	_	_	_	_	_
28	eventually	_	_	RB	_	_	_	_	_
29	producing	_	_	VBG	_	_	_	_	_
30	total	_	_	JJ	_	_	_	_	_
31	blindness	_	_	NN	_	_	_	_	_
32	in	_	_	IN	_	_	_	_	_
33	the	_	_	DT	_	_	_	_	_
34	worst	_	_	JJS	_	_	_	_	_
35	case	_	_	NN	_	_	_	_	_
36	scenario	_	_	NN	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	Also	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	Retinal	_	_	NNP	_	_	_	_	_
5	Vein	_	_	NNP	_	_	_	_	_
6	Occlusion	_	_	NNP	_	_	_	_	_
7	(	_	_	-LRB-	_	_	_	_	_
8	RVO	_	_	NN	_	_	_	_	_
9	)	_	_	-RRB-	_	_	_	_	_
10	produces	_	_	VBZ	_	_	_	_	_
11	a	_	_	DT	_	_	_	_	_
12	problematic	_	_	JJ	_	_	_	_	_
13	loss	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	vascularity	_	_	NN	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	a	_	_	DT	_	_	_	_	_
18	progressive	_	_	JJ	_	_	_	_	_
19	vision	_	_	NN	_	_	_	_	_
20	loss	_	_	NN	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	With	_	_	IN	_	_	_	_	_
2	these	_	_	DT	_	_	_	_	_
3	representative	_	_	JJ	_	_	_	_	_
4	examples	_	_	NNS	_	_	_	_	_
5	among	_	_	IN	_	_	_	_	_
6	many	_	_	JJ	_	_	_	_	_
7	others	_	_	NNS	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	it	_	_	PRP	_	_	_	_	_
10	is	_	_	VBZ	_	_	_	_	_
11	clear	_	_	JJ	_	_	_	_	_
12	that	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	retinal	_	_	JJ	_	_	_	_	_
15	vascular	_	_	JJ	_	_	_	_	_
16	integrity	_	_	NN	_	_	_	_	_
17	is	_	_	VBZ	_	_	_	_	_
18	related	_	_	VBN	_	_	_	_	_
19	with	_	_	IN	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	Visual	_	_	NNP	_	_	_	_	_
22	Acuity	_	_	NNP	_	_	_	_	_
23	(	_	_	-LRB-	_	_	_	_	_
24	VA	_	_	NNP	_	_	_	_	_
25	)	_	_	-RRB-	_	_	_	_	_
26	of	_	_	IN	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	patients	_	_	NNS	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	Commonly	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	to	_	_	TO	_	_	_	_	_
4	estimate	_	_	VB	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	VA	_	_	NNP	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	given	_	_	VBN	_	_	_	_	_
10	patient	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	it	_	_	PRP	_	_	_	_	_
13	is	_	_	VBZ	_	_	_	_	_
14	necessary	_	_	JJ	_	_	_	_	_
15	to	_	_	TO	_	_	_	_	_
16	perform	_	_	VB	_	_	_	_	_
17	different	_	_	JJ	_	_	_	_	_
18	rudimentary	_	_	JJ	_	_	_	_	_
19	tests	_	_	NNS	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	particular	_	_	JJ	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	these	_	_	DT	_	_	_	_	_
5	tests	_	_	NNS	_	_	_	_	_
6	are	_	_	VBP	_	_	_	_	_
7	normally	_	_	RB	_	_	_	_	_
8	related	_	_	VBN	_	_	_	_	_
9	with	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	analysis	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	ability	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	patient	_	_	NN	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	observe	_	_	VB	_	_	_	_	_
20	characteristic	_	_	JJ	_	_	_	_	_
21	objects	_	_	NNS	_	_	_	_	_
22	of	_	_	IN	_	_	_	_	_
23	different	_	_	JJ	_	_	_	_	_
24	sizes	_	_	NNS	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	at	_	_	IN	_	_	_	_	_
27	different	_	_	JJ	_	_	_	_	_
28	distances	_	_	NNS	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	Consequently	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	final	_	_	JJ	_	_	_	_	_
5	VA	_	_	NN	_	_	_	_	_
6	estimation	_	_	NN	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	subjective	_	_	JJ	_	_	_	_	_
9	whereas	_	_	IN	_	_	_	_	_
10	its	_	_	PRP$	_	_	_	_	_
11	process	_	_	NN	_	_	_	_	_
12	is	_	_	VBZ	_	_	_	_	_
13	tedious	_	_	JJ	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	slow	_	_	JJ	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	that	_	_	DT	_	_	_	_	_
3	context	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	any	_	_	DT	_	_	_	_	_
6	technological	_	_	JJ	_	_	_	_	_
7	contribution	_	_	NN	_	_	_	_	_
8	that	_	_	WDT	_	_	_	_	_
9	avoids	_	_	VBZ	_	_	_	_	_
10	or	_	_	CC	_	_	_	_	_
11	facilitates	_	_	VBZ	_	_	_	_	_
12	this	_	_	DT	_	_	_	_	_
13	revision	_	_	NN	_	_	_	_	_
14	process	_	_	NN	_	_	_	_	_
15	is	_	_	VBZ	_	_	_	_	_
16	extremely	_	_	RB	_	_	_	_	_
17	desired	_	_	VBN	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	ophthalmic	_	_	JJ	_	_	_	_	_
21	field	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Given	_	_	VBN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	potential	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	OCTA	_	_	NNP	_	_	_	_	_
7	image	_	_	NN	_	_	_	_	_
8	modality	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	over	_	_	IN	_	_	_	_	_
11	recent	_	_	JJ	_	_	_	_	_
12	years	_	_	NNS	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	several	_	_	JJ	_	_	_	_	_
15	clinical	_	_	JJ	_	_	_	_	_
16	studies	_	_	NNS	_	_	_	_	_
17	were	_	_	VBD	_	_	_	_	_
18	published	_	_	VBN	_	_	_	_	_
19	demonstrating	_	_	VBG	_	_	_	_	_
20	its	_	_	PRP$	_	_	_	_	_
21	utility	_	_	NN	_	_	_	_	_
22	in	_	_	IN	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	analysis	_	_	NN	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	different	_	_	JJ	_	_	_	_	_
27	vascular	_	_	JJ	_	_	_	_	_
28	diseases	_	_	NNS	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	Hence	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	Balaratnasingam	_	_	NNP	_	_	_	_	_
4	et	_	_	FW	_	_	_	_	_
5	al.	_	_	FW	_	_	_	_	_
6	demonstrated	_	_	VBN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	their	_	_	PRP$	_	_	_	_	_
9	study	_	_	NN	_	_	_	_	_
10	that	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	VA	_	_	NNP	_	_	_	_	_
13	is	_	_	VBZ	_	_	_	_	_
14	correlated	_	_	VBN	_	_	_	_	_
15	with	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	Foveal	_	_	NNP	_	_	_	_	_
18	Avascular	_	_	NNP	_	_	_	_	_
19	Zone	_	_	NNP	_	_	_	_	_
20	(	_	_	-LRB-	_	_	_	_	_
21	FAZ	_	_	NNP	_	_	_	_	_
22	)	_	_	-RRB-	_	_	_	_	_
23	in	_	_	IN	_	_	_	_	_
24	patients	_	_	NNS	_	_	_	_	_
25	with	_	_	IN	_	_	_	_	_
26	DR	_	_	NNP	_	_	_	_	_
27	and	_	_	CC	_	_	_	_	_
28	RVO	_	_	NNP	_	_	_	_	_
29	diseases	_	_	NNS	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	Other	_	_	JJ	_	_	_	_	_
2	clinical	_	_	JJ	_	_	_	_	_
3	studies	_	_	NNS	_	_	_	_	_
4	related	_	_	VBN	_	_	_	_	_
5	different	_	_	JJ	_	_	_	_	_
6	manual	_	_	JJ	_	_	_	_	_
7	biomarkers	_	_	NNS	_	_	_	_	_
8	extracted	_	_	VBN	_	_	_	_	_
9	from	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	OCTA	_	_	NNP	_	_	_	_	_
12	images	_	_	NNS	_	_	_	_	_
13	with	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	VA	_	_	NNP	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	patient	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_
20	Wei	_	_	NNP	_	_	_	_	_
21	et	_	_	FW	_	_	_	_	_
22	al.	_	_	FW	_	_	_	_	_
23	demonstrated	_	_	VBD	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	adequate	_	_	JJ	_	_	_	_	_
26	repeatability	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	vascular	_	_	JJ	_	_	_	_	_
30	density	_	_	NN	_	_	_	_	_
31	as	_	_	IN	_	_	_	_	_
32	representative	_	_	JJ	_	_	_	_	_
33	biomarker	_	_	NN	_	_	_	_	_
34	in	_	_	IN	_	_	_	_	_
35	healthy	_	_	JJ	_	_	_	_	_
36	subjects	_	_	NNS	_	_	_	_	_
37	in	_	_	IN	_	_	_	_	_
38	both	_	_	CC	_	_	_	_	_
39	macular	_	_	JJ	_	_	_	_	_
40	and	_	_	CC	_	_	_	_	_
41	optic	_	_	JJ	_	_	_	_	_
42	disk	_	_	NN	_	_	_	_	_
43	regions	_	_	NNS	_	_	_	_	_
44	.	_	_	.	_	_	_	_	_


1	Posteriorly	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	Vivien	_	_	NNP	_	_	_	_	_
4	at	_	_	IN	_	_	_	_	_
5	al.	_	_	FW	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	demonstrated	_	_	VBD	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	influence	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	glaucoma	_	_	NN	_	_	_	_	_
13	disease	_	_	NN	_	_	_	_	_
14	over	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	vessel	_	_	NN	_	_	_	_	_
17	tree	_	_	NN	_	_	_	_	_
18	characteristics	_	_	NNS	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	obtaining	_	_	VBG	_	_	_	_	_
21	as	_	_	IN	_	_	_	_	_
22	conclusions	_	_	NNS	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	absence	_	_	NN	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	retinal	_	_	JJ	_	_	_	_	_
27	vascularity	_	_	NN	_	_	_	_	_
28	in	_	_	IN	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	pathological	_	_	JJ	_	_	_	_	_
31	cases	_	_	NNS	_	_	_	_	_
32	over	_	_	IN	_	_	_	_	_
33	a	_	_	DT	_	_	_	_	_
34	control	_	_	NN	_	_	_	_	_
35	group	_	_	NN	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_


1	Given	_	_	VBN	_	_	_	_	_
2	its	_	_	PRP$	_	_	_	_	_
3	novelty	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	there	_	_	EX	_	_	_	_	_
6	exists	_	_	VBZ	_	_	_	_	_
7	a	_	_	DT	_	_	_	_	_
8	limited	_	_	JJ	_	_	_	_	_
9	number	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	computational	_	_	JJ	_	_	_	_	_
12	proposals	_	_	NNS	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	aid	_	_	VB	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	diagnosis	_	_	NN	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	monitoring	_	_	NN	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	pathologies	_	_	NNS	_	_	_	_	_
21	with	_	_	IN	_	_	_	_	_
22	this	_	_	DT	_	_	_	_	_
23	image	_	_	NN	_	_	_	_	_
24	modality	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	fact	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	existing	_	_	VBG	_	_	_	_	_
6	works	_	_	NNS	_	_	_	_	_
7	are	_	_	VBP	_	_	_	_	_
8	mainly	_	_	RB	_	_	_	_	_
9	based	_	_	VBN	_	_	_	_	_
10	on	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	extraction	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	characteristic	_	_	JJ	_	_	_	_	_
15	biomarkers	_	_	NNS	_	_	_	_	_
16	in	_	_	IN	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	OCTA	_	_	NNP	_	_	_	_	_
19	images	_	_	NNS	_	_	_	_	_
20	or	_	_	CC	_	_	_	_	_
21	improving	_	_	VBG	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	image	_	_	NN	_	_	_	_	_
24	quality	_	_	NN	_	_	_	_	_
25	to	_	_	TO	_	_	_	_	_
26	facilitate	_	_	VB	_	_	_	_	_
27	its	_	_	PRP$	_	_	_	_	_
28	posterior	_	_	JJ	_	_	_	_	_
29	analysis	_	_	NN	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	As	_	_	IN	_	_	_	_	_
2	reference	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	Díaz	_	_	NNP	_	_	_	_	_
5	et	_	_	FW	_	_	_	_	_
6	al.	_	_	FW	_	_	_	_	_
7	briefly	_	_	RB	_	_	_	_	_
8	introduced	_	_	VBD	_	_	_	_	_
9	a	_	_	DT	_	_	_	_	_
10	method	_	_	NN	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	automatically	_	_	RB	_	_	_	_	_
13	extract	_	_	VB	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	measure	_	_	VB	_	_	_	_	_
16	generally	_	_	RB	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	Vascular	_	_	JJ	_	_	_	_	_
19	Density	_	_	NNP	_	_	_	_	_
20	(	_	_	-LRB-	_	_	_	_	_
21	VD	_	_	NN	_	_	_	_	_
22	)	_	_	-RRB-	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	Also	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	authors	_	_	NNS	_	_	_	_	_
5	proposed	_	_	VBD	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	method	_	_	NN	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	extract	_	_	VB	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	measure	_	_	VB	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	FAZ	_	_	NNP	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	healthy	_	_	JJ	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	DR	_	_	NNP	_	_	_	_	_
18	OCTA	_	_	NNP	_	_	_	_	_
19	images	_	_	NNS	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	they	_	_	PRP	_	_	_	_	_
22	performed	_	_	VBD	_	_	_	_	_
23	a	_	_	DT	_	_	_	_	_
24	FAZ	_	_	NNP	_	_	_	_	_
25	circularity	_	_	NN	_	_	_	_	_
26	study	_	_	NN	_	_	_	_	_
27	in	_	_	IN	_	_	_	_	_
28	healthy	_	_	JJ	_	_	_	_	_
29	and	_	_	CC	_	_	_	_	_
30	pathological	_	_	JJ	_	_	_	_	_
31	images	_	_	NNS	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_
33	Alam	_	_	NNP	_	_	_	_	_
34	et	_	_	FW	_	_	_	_	_
35	al.	_	_	FW	_	_	_	_	_
36	proposed	_	_	VBD	_	_	_	_	_
37	different	_	_	JJ	_	_	_	_	_
38	features	_	_	NNS	_	_	_	_	_
39	extracted	_	_	VBN	_	_	_	_	_
40	from	_	_	IN	_	_	_	_	_
41	the	_	_	DT	_	_	_	_	_
42	OCTA	_	_	NNP	_	_	_	_	_
43	images	_	_	NNS	_	_	_	_	_
44	,	_	_	,	_	_	_	_	_
45	namely	_	_	RB	_	_	_	_	_
46	,	_	_	,	_	_	_	_	_
47	the	_	_	DT	_	_	_	_	_
48	vessel	_	_	NN	_	_	_	_	_
49	tortuosity	_	_	NN	_	_	_	_	_
50	,	_	_	,	_	_	_	_	_
51	the	_	_	DT	_	_	_	_	_
52	mean	_	_	JJ	_	_	_	_	_
53	diameter	_	_	NN	_	_	_	_	_
54	of	_	_	IN	_	_	_	_	_
55	the	_	_	DT	_	_	_	_	_
56	blood	_	_	NN	_	_	_	_	_
57	vessels	_	_	NNS	_	_	_	_	_
58	,	_	_	,	_	_	_	_	_
59	the	_	_	DT	_	_	_	_	_
60	semi-automatic	_	_	JJ	_	_	_	_	_
61	FAZ	_	_	NN	_	_	_	_	_
62	area	_	_	NN	_	_	_	_	_
63	,	_	_	,	_	_	_	_	_
64	the	_	_	DT	_	_	_	_	_
65	FAZ	_	_	NN	_	_	_	_	_
66	irregularity	_	_	NN	_	_	_	_	_
67	and	_	_	CC	_	_	_	_	_
68	the	_	_	DT	_	_	_	_	_
69	density	_	_	NN	_	_	_	_	_
70	of	_	_	IN	_	_	_	_	_
71	the	_	_	DT	_	_	_	_	_
72	parafoveal	_	_	JJ	_	_	_	_	_
73	avascular	_	_	JJ	_	_	_	_	_
74	region	_	_	NN	_	_	_	_	_
75	using	_	_	VBG	_	_	_	_	_
76	fractal	_	_	JJ	_	_	_	_	_
77	dimensions	_	_	NNS	_	_	_	_	_
78	.	_	_	.	_	_	_	_	_
79	Guo	_	_	NNP	_	_	_	_	_
80	et	_	_	FW	_	_	_	_	_
81	al.	_	_	FW	_	_	_	_	_
82	segmented	_	_	VBN	_	_	_	_	_
83	and	_	_	CC	_	_	_	_	_
84	quantified	_	_	VBD	_	_	_	_	_
85	avascular	_	_	JJ	_	_	_	_	_
86	ischemic	_	_	JJ	_	_	_	_	_
87	zones	_	_	NNS	_	_	_	_	_
88	with	_	_	IN	_	_	_	_	_
89	map	_	_	NN	_	_	_	_	_
90	probabilities	_	_	NNS	_	_	_	_	_
91	that	_	_	WDT	_	_	_	_	_
92	were	_	_	VBD	_	_	_	_	_
93	extracted	_	_	VBN	_	_	_	_	_
94	by	_	_	IN	_	_	_	_	_
95	a	_	_	DT	_	_	_	_	_
96	deep	_	_	JJ	_	_	_	_	_
97	convolutional	_	_	JJ	_	_	_	_	_
98	neural	_	_	JJ	_	_	_	_	_
99	network	_	_	NN	_	_	_	_	_
100	.	_	_	.	_	_	_	_	_
101	Wang	_	_	NNP	_	_	_	_	_
102	et	_	_	FW	_	_	_	_	_
103	al.	_	_	FW	_	_	_	_	_


1	proposed	_	_	VBD	_	_	_	_	_
2	a	_	_	DT	_	_	_	_	_
3	method	_	_	NN	_	_	_	_	_
4	to	_	_	TO	_	_	_	_	_
5	produce	_	_	VB	_	_	_	_	_
6	mosaics	_	_	NNS	_	_	_	_	_
7	using	_	_	VBG	_	_	_	_	_
8	different	_	_	JJ	_	_	_	_	_
9	overlapping	_	_	VBG	_	_	_	_	_
10	OCTA	_	_	NN	_	_	_	_	_
11	images	_	_	NNS	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	increasing	_	_	VBG	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	wide	_	_	JJ	_	_	_	_	_
16	field	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	vision	_	_	NN	_	_	_	_	_
19	for	_	_	IN	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	posterior	_	_	JJ	_	_	_	_	_
22	clinical	_	_	JJ	_	_	_	_	_
23	analysis	_	_	NN	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_
25	Wei	_	_	NNP	_	_	_	_	_
26	et	_	_	FW	_	_	_	_	_
27	al.	_	_	FW	_	_	_	_	_
28	improved	_	_	VBD	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	quality	_	_	NN	_	_	_	_	_
31	of	_	_	IN	_	_	_	_	_
32	the	_	_	DT	_	_	_	_	_
33	OCTA	_	_	NNP	_	_	_	_	_
34	scans	_	_	NNS	_	_	_	_	_
35	in	_	_	IN	_	_	_	_	_
36	their	_	_	PRP$	_	_	_	_	_
37	work	_	_	NN	_	_	_	_	_
38	whereas	_	_	IN	_	_	_	_	_
39	Camino	_	_	NNP	_	_	_	_	_
40	et	_	_	FW	_	_	_	_	_
41	al.	_	_	FW	_	_	_	_	_
42	identified	_	_	VBN	_	_	_	_	_
43	existing	_	_	VBG	_	_	_	_	_
44	shadow	_	_	NN	_	_	_	_	_
45	artifacts	_	_	NNS	_	_	_	_	_
46	that	_	_	WDT	_	_	_	_	_
47	typically	_	_	RB	_	_	_	_	_
48	appear	_	_	VBP	_	_	_	_	_
49	in	_	_	IN	_	_	_	_	_
50	the	_	_	DT	_	_	_	_	_
51	OCTA	_	_	NNP	_	_	_	_	_
52	images	_	_	NNS	_	_	_	_	_
53	to	_	_	TO	_	_	_	_	_
54	improve	_	_	VB	_	_	_	_	_
55	the	_	_	DT	_	_	_	_	_
56	visualization	_	_	NN	_	_	_	_	_
57	and	_	_	CC	_	_	_	_	_
58	facilitate	_	_	VB	_	_	_	_	_
59	their	_	_	PRP$	_	_	_	_	_
60	inspection	_	_	NN	_	_	_	_	_
61	.	_	_	.	_	_	_	_	_

